ABRILADA Trademark

Trademark Overview

On Friday, June 9, 2017, a trademark application was filed for ABRILADA with the United States Patent and Trademark Office. The USPTO has given the ABRILADA trademark a serial number of 87482653. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 5, 2021. This trademark is owned by Pfizer Inc.. The ABRILADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
abrilada

General Information

Serial Number87482653
Word MarkABRILADA
Filing DateFriday, June 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Translation of Words in MarkThe wording "ABRILADA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, July 6, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 3, 2020EXTENSION 5 GRANTED
Monday, October 26, 2020EXTENSION 5 FILED
Tuesday, November 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 26, 2020TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 15, 2020EXTENSION 4 GRANTED
Friday, May 15, 2020EXTENSION 4 FILED
Friday, May 15, 2020TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019EXTENSION 3 GRANTED
Monday, November 25, 2019EXTENSION 3 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Monday, November 18, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, November 15, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2019EXTENSION 2 GRANTED
Wednesday, May 22, 2019EXTENSION 2 FILED
Wednesday, May 22, 2019TEAS EXTENSION RECEIVED
Wednesday, November 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 26, 2018EXTENSION 1 GRANTED
Monday, November 26, 2018EXTENSION 1 FILED
Monday, November 26, 2018TEAS EXTENSION RECEIVED
Tuesday, May 29, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 26, 2017NON-FINAL ACTION E-MAILED
Saturday, August 26, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 23, 2017ASSIGNED TO EXAMINER
Friday, June 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

abrilada preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases